Clinical efficacy of chlorhexidine chips and tetracycline fibers as an adjunct to non surgical periodontal therapy

Munishwar Singh; A. K. Shreehari; P. K. Garg; Sangeeta Singh

doi:10.4103/2278-9626.134840

European Journal of General Dentistry, Table of Contents

CC BY-NC-ND 4.0 · European Journal of General Dentistry 2014; 3(02): 134-139
DOI: 10.4103/2278-9626.134840

Original Article

Clinical efficacy of chlorhexidine chips and tetracycline fibers as an adjunct to non surgical periodontal therapy

Authors

Munishwar Singh

Division of Periodontology, Department of Dental Surgery, Armed Forces Medical College, Pune, Maharashtra, India
A. K. Shreehari

Division of Periodontology, Department of Dental Surgery, Armed Forces Medical College, Pune, Maharashtra, India
P. K. Garg

Division of Periodontology, Department of Dental Surgery, Armed Forces Medical College, Pune, Maharashtra, India
Sangeeta Singh

Division of Periodontology, Department of Dental Surgery, Armed Forces Medical College, Pune, Maharashtra, India

Abstract

PDF Download

Abstract

Context: Local drug delivery agents. Aims: To clinically evaluate the efficacy of Chlorhexidine chip (PerioCol™ CG) with Tetracycline fibers (Periodontal Plus AB™). Settings and Design: Randomized controlled, split mouth study design with an observation period of six months. Materials and Methods: Patients were allocated in 3 experimental treatment groups, Group A: SRP + CHX Chip, Group B: SRP + Tetracycline fibers, and Group C: SRP alone (control group). 420 bleeding sites in 35 patients (18 females and 17 males) with chronic periodontitis (5-8mm probing depth), were evaluated clinically for pocket probing depth (PD), Clinical Attachment level (CAL), and Bleeding on Probing (BoP). Statistical Analysis: T-test and CV. Results: All the treatment groups were found to be efficacious as demonstrated by improvement in PD, CAL, and BoP. In the short term, CHX group showed increased gain of CAL but on long term observation the Tetracycline fiber group showed better consistent clinical results in comparison to the other two groups. Conclusions: Group B (SRP + Tetracycline fibers) resulted in better optimum clinical results in comparison to the other two treatment groups.

Keywords

Chlorhexidine chips - chronic periodontitis - local drug delivery - periodontal pocket - tetracycline fibers

PDF (1283 kb)

References

References
1 Goodson JM. Controlled drug delivery: A new means of treatment of dental diseases. Compend Contin Educ Dent 1985;6:27-32,35-36.
2 Greenstein G, Polson A. The role of local drug delivery in management of periodontal disease: A comprehensive review. J Periodontol 1998;69:507-20.
3 Greenstein G, Tonetti M. The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology. J Periodontol 2000;71:125-40.
4 Rath SK, Singh M. Comparative clinical and microbiological efficacy of mouthwashes containing 0.2% and 0.12% chlorhexidine. Dent Res J 2013;10:364-9.
5 Soskolne WA, Heasman PA, Stabholz A, Smart GJ, Palmer M, Flashner M, et al. Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multi-center study. J Periodontol 1997;68:32-8.
6 Daneshmand N, Jorgensen MG, Nowzari H, Morrison JL. Slots J. Initial effect of controlled release chlorhexidine on subgingival microorganisms. J Periodontal Res 2002;37:375-9.
7 Jeffcoat MK, Bray KS, Ciancio SG, Dentino AR, Fine DH, Gordon JM, et al. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planning alone. J Periodontol 1998;69:989-97.
8 Azmak N, Atilla G, Luoto H, Sorsa T. The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid. J Periodontol 2002;73:608-15.
9 Grisi DC, Salvador SL, Figueiredo LC, Souza SL, Novaes AB, Grisi MF. Effect of a controlled release chlorhexidine chip on clinical and microbiological parameters of periodontal syndrome. J Clin Periodontol 2002;29:875-81.
10 In: Dumitrescu, AL. editor. Chemotherapeutic Agents. Antibiotics And Antiseptics in Periodontal Therapy. 1 st ed. Springer; 2010. p. 213.
11 Quirynen M, Teughels W, De Soete M, van Steenberghe D. Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: Microbiological aspects. Periodontol 2000 2002;28:72-90.
12 Verma E, Belludi SA, Banthia R. Local drug delivery with chlorhexidine chip and tetracycline fibers as an adjunct to mechanical therapy in isolated periodontal pockets - A case report. Int J Clin Dent 2011;4:383-84.
13 Srivastava R, Verma PK, Tandon P, Kumar R, Gupta KK, Srivastava A. Chlorhexidine chip and tetracycline fibers as adjunct to scaling and root planing - A clinical study. Braz J Oral Sci 2009;8:201-5.
14 Renvert S, Persson GR. A systematic review on the use of residual probing depth, bleeding on probing and furcation status following initial periodontal therapy to predict further attachment and tooth loss. J Clin Periodontol 2002;29:82-9.
15 Badersten A, Nilveus R, Egelberg J. Scores of plaque, bleeding, suppuration and probing depth to predict probing attachment loss. 5 years of observation following nonsurgical periodontal therapy. J Clin Periodontol 1990;17:102-7.
16 Loesche WJ, Schmidt E, Smith BA, Morrison EC, Caffesse R, Hujoel P. Effects of metronidazole on periodontal treatment needs. J Periodontol 1991;62:247-57.
17 Loos B, Claffey N, Crigger M. Effects of oral hygiene measures on clinical and microbiological parameters of periodontal disease. J Clin Periodontol 1988;15:211-6.
18 Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J Clin Periodont 1984;11:63-76.
19 Berglundh T, Krok L, Liljenberg B, Westfelt E, Serino G, Lindhe J. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial. J Clin Periodont 1998;25:354-62.
20 Ciancio SG, Cobb CM, Leung M. Tissue concentration and localization of tetracycline following site-specific tetracycline fiber therapy. J Periodont 1992;63:849-53.
21 Golub LM, Ramamurthy N, McNamara TF, Gomes B, Wolff M, Casino A, et al. Tetracyclines inhibit tissue collagenase activity. J Periodontal Res 1984;19:651-5.
22 Morrison SL, Cobb CM, Kazakos GM, Killoy WJ. Root surface characteristics associated with subgingival placement of monolithic tetracycline-impregnated fibers. J Periodontol 1992;63:137-43.
23 Kazakos GM, Cobb CM, Morrison SL, Barker BF, Killoy WJ. Gingival response to subgingival placement of monolithic tetracycline-impregnated fibers: Microscopic observations. Int J Periodontics Restorative Dent 1993;13:150-71.
24 Purucker P, Mertes H, Goodson JM, Bernimoulin JP. Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J Periodontol 2001;72:1241-5.
25 Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Clinical response. J Periodontol 1995;66:692-9.